These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12419017)

  • 1. Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration.
    Kubo JI; Ohigashi Y; Hamabe M; Ogawara KI; Higaki K; Saito H; Kimura T
    Xenobiotica; 2002 Oct; 32(10):879-93. PubMed ID: 12419017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat.
    al-Humayyd MS
    Chemotherapy; 1997; 43(2):77-85. PubMed ID: 9084915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of clarithromycin by rat lung cells.
    Kohno Y; Yoshida H; Suwa T; Suga T
    J Antimicrob Chemother; 1990 Oct; 26(4):503-13. PubMed ID: 2147673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
    Suarez-Mier G; Giguère S; Lee EA
    J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties.
    Ishii K; Saito Y; Itai S; Nemoto M; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1998 Feb; 24(2):129-37. PubMed ID: 15605442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.
    Novelli A; Fallani S; Cassetta MI; Arrigucci S; Mazzei T
    J Chemother; 2002 Dec; 14(6):584-90. PubMed ID: 12583550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen.
    Periti P; Mazzei T
    J Chemother; 1999 Feb; 11(1):11-27. PubMed ID: 10078776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals.
    Berlin S; Spieckermann L; Oswald S; Keiser M; Lumpe S; Ullrich A; Grube M; Hasan M; Venner M; Siegmund W
    Mol Pharm; 2016 Mar; 13(3):1089-99. PubMed ID: 26808255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of clarithromycin.
    Rodvold KA
    Clin Pharmacokinet; 1999 Nov; 37(5):385-98. PubMed ID: 10589373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats].
    Yoshida H; Furuta T
    Jpn J Antibiot; 1999 Jul; 52(7):497-503. PubMed ID: 10516929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.
    Conte JE; Golden JA; Duncan S; McKenna E; Zurlinden E
    Antimicrob Agents Chemother; 1995 Feb; 39(2):334-8. PubMed ID: 7726492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the chemical structure of O-methyl erythromycin derivatives and their affinity to the lung].
    Yoshida H; Furuta T
    Jpn J Antibiot; 2000 Oct; 53(10):615-22. PubMed ID: 11190046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic difference in gastrointestinal excretion of clarithromycin and roxithromycin.
    Arimori K; Miyamoto S; Fukuda K; Nakamura C; Nakano M
    Biopharm Drug Dispos; 1998 Oct; 19(7):433-8. PubMed ID: 9818709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.
    Dalbøge CS; Nielsen XC; Dalhoff K; Alffenaar JW; Duno M; Buchard A; Uges DR; Jensen AG; Jürgens G; Pressler T; Johansen HK; Høiby N
    J Cyst Fibros; 2014 Mar; 13(2):179-85. PubMed ID: 24035278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
    Javsicas LH; Giguère S; Womble AY
    J Vet Pharmacol Ther; 2010 Aug; 33(4):383-8. PubMed ID: 20646201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin.
    Boruchoff SE; Sturgill MG; Grasing KW; Seibold JR; McCrea J; Winchell GA; Kusma SE; Deutsch PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):351-9. PubMed ID: 10801243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.